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ABSTRACT OF THE THESIS
HISTOLOGICAL CHARACTERIZATION OF INTER ICTAL EPILEPTIFORM
DISCHARGES GENERATING BRAIN REGIONS USING A PRECLINICAL
MODEL OF FOCAL CORTICAL DYSPLASIA
by
Abhay Shivaji Deshmukh
Florida International University, 2015
Miami, Florida
Professor Jorge J. Riera, Major Professor
Current

clinical

practice

of

resective

surgery

in

focal

epilepsy

involves

electroencephalogram (EEG) brain source imaging to localize irritative brain areas from
where Inter-ictal epileptiform discharges (IEDs) emerge, useful to localize the seizuresonset zones. Unfortunately, there are no previous systematic studies to characterize the
pathophysiological mechanisms and abnormal cellular substrates in these irritative areas
since histological data are available only from the final resective zones. To address this
issue we applied a combination of EEG brain imaging described by Bae et al. (2015)
using cutting-edge technology for high-density scalp EEG in rodents and histological
analysis on a chronic rat model of focal cortical dysplasia. Post-mortem brain sections
were stained for anatomical, functional and inflammatory biomarkers. Abnormal
anatomical structures and increased expression of inflammatory biomarkers were found
in the irritative regions. We conclude that IED-based brain source imaging can help to
localize abnormal tissues highly prospective for epileptogenesis.
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1. INTRODUCTION
1.1 FOCAL EPILEPSY
Epilepsy is a diverse set of chronic neurological disorders characterized by
seizures. There are several types of epilepsies, but those named focal are the ones of
special interest for this thesis. Focal or partial epilepsy is characterized by disturbance in
electrical activity followed by seizures. Typical symptoms include unconsciousness,
muscle rigidity, loss of muscle tone, convulsions, impairment of sensory functions, and
automatism. Refractory focal epilepsy is a condition where antiepileptic drugs are
ineffective against seizures. Focal epilepsies, also classified as partial epilepsies, are in
many cases refractory. There are two major groups of focal epilepsy: temporal lobe
epilepsy (TLE) which is more incident in adults and focal cortical dysplasia (FCD)
which is more incident in children (Battaglia et al., 2009; Cavalheiro et al., 1995; Curia
et al., 2008). FCD which is the one studied in this thesis results from malformations of
cortical development that become electrically excitable with time. FCD forms a
heterogeneous group of cortical malformations of development (Montenegro et al.,
2003) which resemble the following properties.
1) Cortical architecture abnormalities: Columnar disorganization (formation of
vertically oriented microcolumns consisting of at least eight neurons) and alterations in
6-layered tangential composition of the cortex (Montenegro et al., 2003).
2) Cytological abnormalities: Hypertrophic neurons outside typical location in layer V,
immature neurons, round or oval cells with large nucleus and thin rim of cytoplasm,
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absent in matured cortex, dysmorphic neurons with abnormal size and morphology of
axons and dendrites, as well as increased accumulation of neurofilament proteins,
balloon cells, usually large cells with ill-defined membrane, single or multiple eccentric
nuclei and eosinophilic cytoplasm, demonstrating immunohistochemical features of
neuronal and glial lineage (Montenegro et al., 2003).
1.2 PRESURGICAL EVALUATION OF FCD PATIENTS
The primary aim of the presurgical evaluation of patients with refractory focal
epilepsy is to determine the location of the epileptogenic zone which is a tissue region
responsible for seizure generation and that has to be removed to stop the seizures.
Although surface electroencephalography (EEG) recordings are less sensitive than
intracranial recordings, they still provide the best overview and, therefore, EEG based
brain source imaging of interictal epileptiform discharges (IEDs) is the most practical
and efficient method to localize and determine the epileptogenic region (Noachtar et al.,
2009; Verhellen et al., 2007).
1.3 INTERICTAL EPILEPTIFORM DISCHARGES (IEDS)
The term “spike discharge” describes a pattern of EEG characterized by a spike
followed by a wave in epileptic subjects. Spike discharges are observed not only during
the ictal phases, when subject is experiencing seizures but also during the interictal
phases, characterized by the absence of seizures. The spike discharges during the
interictal phase are called as interictal epileptiform discharges. There is no standard
definition of the IEDs, but are generally classified in typical sub-types as spikes (20-70
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ms in duration, 15-50 Hz) and sharp-waves (70-200 ms in duration, 5-15 Hz) (Tyvaert
et al., 2008; Grova et al., 2006; Neymotin et al., 2010).
1.4 ANIMAL MODEL FOR FCD
Historically, animal models of epilepsy have been mainly developed in rodents.
It is because the rat is already the lowest appropriate mammalian preparation to study
epilepsy. In particular, it has been very difficult to obtain an appropriate animal model
for focal cortical dysplasia (FCD), as methylazoxymethanol acetate and pilocarpine
(MAM-PILO) double hit model recently developed (Colciaghi et al., 2011) and
proposed for our study using Wistar rats (details given in section 2.1). Rat model for
FCD created by prenatal treatment of methylazoxymethanol acetate (MAM) has a
potential to mimic the pathological and clinical features of focal epilepsy thus MAMPILO model is an important model for FCD. Improvements in the strategies to create
chronic focal epilepsy in rats and the recent development of cutting-edge technology for
high-density scalp EEG in small animals make this particular preclinical model
attractive.
1.5 IED-BASED BRAIN SOURCE IMAGING (BSI)
In this study, 32-channel EEG recordings were collected and analysed from
chronic rat models of focal cortical dysplasia. In order to determine the candidate tissue
to be resected in these animal models, IEDs from EEG were selected using their
characteristic features reported in literature (Bortel et al., 2010) and the IEDs sources
(irritative zones) were estimated by solving the EEG inverse problem (Kaiboriboon et
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al., 2012). The inverse problem consists of localizing in the 3D brain space the current
sources that produce the IEDs. To that end, it is necessary to make some assumptions
about the nature of these current sources. Standardized low-resolution brain
electromagnetic tomography (sLORETA) (Pascual-Marqui, et al, 2002) is one such
model which considers two sources of variation: the variation of the actual sources, and
if present, variation due to noisy measurements and is based on the assumption that
multiple sources can be simultaneously active across many locations at a given time.
With context to our study, sLORETA underlies the concept that neighbouring neuronal
populations are more likely to undergo synchronous depolarization during spontaneous
discharge or an evoked response than are non-neighbouring neurons (Verhellen et al.,
2007; Kaiboriboon et al., 2012). However, in practice, a critical issue with the IEDs is
the inconsistencies in the localization of the epileptic zone in an individual case where
solutions of inverse problem give the multiple localized regions for a single IED. The
reasons underlying the inconsistencies in the localization of the epileptogenic zones
could be due to the errors in the proper classification of IEDs and identification of
relevant irritative area by using only information in the IED waveform. To avoid such
inconsistencies we used a specific criterion for source determination, based on
frequency of sources obtained from localization of each IED subtype.
The existence of multiple IED-generating sources could also be due to improper
IED classification. We applied widely recommended methods that classify IED
subtypes using both spatial and temporal profiles based on a multi-way principal
component analysis known as parallel factor analysis (PARAFAC) (Fumikazu
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Miwakeichi et.al, 2004) which is combined with a cluster analysis (Pedreira C, et al.,
2004). This method allows us to decompose the topographic maps and temporal courses
of IEDs as combination of spatial and temporal atoms to reduce the uncertainly in IED
classification.
1.6 HISTOLOGICAL ANALYSIS
As mentioned earlier, localization of the individual IEDs subtypes was performed
through the use of the sLORETA (Pascual-Marqui, et al, 2002). In order to analyse this
methodology, we used histological biomarkers for anatomical, functional, and
inflammatory indicators known to be affected in epilepsy. At the irritative zones
identified from localized IEDs, we compared these histological indexes with the
contralateral cortical region. From histological analysis it was possible to discuss major
molecular and cellular bases that better correlate with the IEDs associated regions.
In the past most of the studies have been focused on determining histological
biomarkers associated with the focal epileptic lesion. In this study we aim to find
correlates between electrically excitable areas, as determined by applied brain source
imaging and IEDs, and focal epilepsy specific histological biomarkers.
1.7 STATEMENT OF RESEARCH
In spite of recent advances in neuroimaging techniques, current clinical practice
of resective surgery in focal epilepsy involves EEG brain source imaging to localize
brain areas named irritatives, from where interictal epileptogenic discharges (IEDs)
emerge to localize the seizures-onset zones (Noachtar et al., 2009; Verhellen et al.,
5

2007). Unfortunately, there are no previous systematic studies available to characterize
the pathophysiological mechanisms and abnormal cellular substrates in these irritative
areas since histological data are available only from the final resective zones. To
address this issue we combined EEG brain source imaging with histological analysis
from the irritative areas which would be only possible using preclinical animal models.
1.8 OBJECTIVE AND HYPOTHESIS
The objective of the project was to characterize the pathophysiological
mechanisms and abnormal cellular substrates of the irritative areas using a preclinical
animal model by combining: a) an animal model of FCD, b) a method for EEG brain
imaging of IED generators, and c) histological data. The following hypothesis was
tested to meet the objective.
H1: Chronic focal epilepsy induces abnormal pathophysiological changes in the
irritative areas; hence these irritative zones are of clinical relevance for pre-surgical
evaluation of patients with refractory focal epilepsy.
1.9 SPECIFIC AIMS
Listed below are the specific aims to test the above mentioned hypothesis. Please refer
to the chapter: materials and methods for details.
Aim 1: To develop a preclinical model of focal cortical dysplasia for Wistar rats.
Aim 2: To develop an accurate methodology for performing EEG brain source analysis
on IEDs.
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Aim 3: To develop a particular protocol to perform histological analysis on the target
irritative tissue.
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2. MATERIALS AND METHODS
All experimental procedures were approved by and carried out in full
compliance with the Institutional Animal Care and Use Committee at Florida
International University (Approval No. 13-004).
2.1 ANIMAL MODEL PREPARATION
All male Wistar rats used to create models with focal cortical dysplasia were
received from Charles River Laboratories. The pharmaco-resistant FCD preclinical
model was established with male Wistar rats following the protocol described
previously by Colciaghi et al. In brief, this protocol includes two major steps: first, the
cortical malformations of this preclinical model were induced prenatally on Embryonic
Day 15 with two doses of methylazoxymethanol (MAM) injections (15mg/kg maternal
body weight) 12 hours apart; second, these MAM-treated rats were intra-peritoneally
(i.p.) injected with pilocarpine (PILO, 300 mg/kg) on post-natal day 28 to induce status
epilepticus (SE). All MAM-PILO rats were monitored by four investigators (YS, RT,
AD and JJR) independently to identify the SE marked by occurrence of continuous
motor seizure activity according to the Racine scale (Racine et.al, 1972). Rats
experiencing SE received intra-peritoneal phenobarbital (20 mg/kg) 90 min after SE
onset to reduce mortality, then were hydrated subcutaneously with Lactate Ringer’s
solution and fed by the investigators to improve the survival rate. Rats not experiencing
SE were euthanized.

After two weeks from onset of SE, rats were observed for

occurrence of seizures for one week to confirm the chronic epileptic models.
Eventually, thirteen MAM-PILO rats survived from this procedure and developed
8

chronic seizures. From this point on, these MAM-PILO rats will be referred to as
epileptic rats. All epileptic rats were housed in standardized cages at a 12h-12h lightdark cycle with food and water ad libitum.

Figure-(1): Methodology Overview. An overview of the methodology illustrating steps
involved in brain source imaging and rat brain scaling for further histological analysis.
9

An overview of the methodology is described in figure-1 with epileptic rat with
EEG-mini cap placed on scalp for EEG recording. A red marking in EEG trace show an
IED subtype to be selected followed by illustration of IED subtype clustered from 32channel scalp EEG. sLORETA localized sources are shown based on selected IEDs.
The coordinates of these localized brain sources were scaled with respect to
experimental brain using Paxinos and Watson atlas as shown in figure-1.

2.2 EEG RECORDING
There is a difficulty for EEG recording in small animals because of small
surface area of scalp compared to human scalp. To solve this problem our group has a
patented technology which provides EEG mini cap with 32 spatial electrodes suitable
for rodent EEG recording (Riera J, et. al., 2011) as shown in figure-1. Weight of the rat
was measured before initial anesthesia with isoflurane (5% for initial induction and then
1-2%, 1 L/min O 2 , 14 PSI) during all the manipulations. This was followed by shaving
of rat scalp and fixing rat head in a stereotaxic frame. The scalp was rubbed with
ethanol (90%) for delipidation and a saline swab was kept on the scalp to keep it wet
until the cap was fixed. After fixing the rat, dexdomitor (dexmedetomidine
hydrochloride, 0.25 mg/kg) which is an analgesic was administered intraperitoneally, to
the rat and isoflurane was gradually reduced to 0.5%. This mixture of dexdomitor and
low dose of isoflurane does not reduce cortical hemodynamic responses (M. Zao etal.;
S. Harris et.al 2014). Prior to the recording, each electrode was filled with high
conductance paste. After fixing the cap on the rat scalp an impendence check was
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carried out to ascertain the performance of each electrode (Riera J, et al., 2011). With
this preparation, EEG ongoing activity was recorded (PZ3, Tucker-Davis Technology)
for a period of thirty minutes. The rat body temperature was maintained using a watercirculating heating pad (TPZ-0510EA, Texas Scientific Instruments, LLC) with a pump
(TP700, Texas Scientific Instruments, LLC). The rat body temperature (~37°C), heart
rate (200-300 beats per minute) and respiration rate (<50 breaths per minute) were
monitored continuously by PowerLab 8/35 data acquisition device and LabChart
software (AD Instruments) to assure that level of anesthesia remained stable throughout
the entire experimental procedures. EEG signals were amplified, filtered (0.5 Hz highpass, and 250 Hz low-pass), and digitized (5 kHz sampling rate, 0.5 μV resolution).

2.3 EEG PROCESSING, PARAFAC AND CLUSTER ANALYSIS
IEDs that included temporal patterns which are spikes (20-70 ms in duration, 1550 Hz) and sharp-waves (70-200 ms in duration, 5-15 Hz), were selected by a
combination of multiple band-pass/notch filters and an auto-thresholding method from
the averaged signals of the 32-channel scalp EEG. The unique multi-linear
decompositions of multi-way arrays of data (more than two dimensions) are possible
under certain conditions according to the principle of Parallel Factor Analysis
(PARAFAC) (Sidiropoulos and Bro, 2000). In PARAFAC, the data is decomposed as a
sum of components (space/frequency/time) for three-way arrays. The important
improvement in PARAFAC as compared to traditional techniques such as PCA or ICA
is that the decomposition of multi-way data is unique even without additional
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orthogonality or independence constraints (Fumikazu Miwakeichi et.al, 2004). Thus we
employed PARAFAC analysis decomposing the EEG data into space/time/sample
components along with super paramagnetic clustering (fig. 2), a clustering method from
statistical mechanics (Pedreira C, et al., 2014). This combination allows identifying
small but consistent differences in the analysed signals. The IED detection method is
similar to those reported in human studies (A. Salek-Haddadi et al, 2006; E. Kobayashi
et al., 2006), as well as animal studies (R. Rathakrishnan et al., 2010; F. Pittau et al.,
2013).
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(A) Cluster Cloud Sub-Types

Spikes

Sharp waves

(B) Raster Plots

Sharp waves

Spikes

Figure-(2): IED Classification. (A) PARAFAC 3D (space/time/sample) clustering based
on k-mean values. (B) Raster plots representing observed clusters with respect to time.
(Colors show respective clusters).
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Subsequently, spikes and sharp-waves were separated into multiple sub-types (fig 3),
using a series of feature extraction and classification methods described previously (R.
Rathakrishnan et al., 2010; F. Pittau et al., 2013). Each sub-type of IEDs was considered
as a unique event. Event-related 32-channel EEG potentials were created by averaging
the EEG data time-locked to the IED onsets within corresponding window size (80-ms
for spikes and 200-ms for sharp-waves).

2.4 sLORETA INVERSE SOLUTION
To define a volume conductor model, the open source software, Brainstorm (Tadel
F, et al, 2011), was used with the MRI atlas for Wistar rats (Valdez-Hernandez P, et al,
2011). However, individual rat’s MRI can also be used to generate the volume
conductor model if available. The input of MRI surface and brain surface were given to
the software and head surface was generated with default setting. For lead field
computation scalp and inner/outer skull surfaces based on MRI were generated (Tadel
F, et al, 2011). The orientation and location of each surface were co-registered with
respect to the MRI using the visualization option (Tadel F, et al, 2011). Using the rat
head picture with three reference points acquired immediately after EEG recording,
their positions were co-registered in the MRI. The same references were used to
generate the electrode positions as the electrode positions are fixed with respect to
reference points. Electrode position matrix (N × 3) based on the three reference points
was generated. Here, N is the number of channels (N = 32) and the column represents
the corresponding x, y, and z coordinate values. Using the generated channel file, the
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location of all electrodes was displayed and confirmed. Any misplaced electrodes were
modified manually (Tadel F, et al, 2011). It was made sure that the final coordinate
system for the electrode positions coincides with the coordinate system used for the
MRI and brain surfaces. The conductivity values which satisfy the ratio of skin, skull,
and brain as 1 : 1/80 : 1 were specified to obtain the lead field matrix based on the
volume conductor model and the electrode positions already created. sLORETA
solution (Pascual-Marqui, R. D. 2001) was obtained based on the computed lead field
matrix and the input EEG signals. By selecting the source estimation method option, the
inverse solution was obtained and estimated sources were plotted (Tadel F, et al, 2011).
sLORETA distributed inverse solution was estimated from the event-related potentials
for each IED sub-type using Brainstorm (fig. 3) (Y. Lu et al., 2004). For each epileptic
rat, surgically accessible location for craniotomy was determined based on the source
locations at the initial phases of each IED sub-type. These source locations were
believed to be associated with irritative zones. A T2-weighted MRI atlas for Wistar rats
was used to calculate the electric lead fields (J. Riera et al, 2004). This atlas is defined
on the Paxinos and Watson’s coordinate system (Y. Zheng et al, 2002).
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Figure-3: Time series and EEG topography for each IED subtype. Analysis performed
at a specific time instance represented by a red line in time series.
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2.5 HISTOLOGY AND sLORETA CO-REGISTRATION
Once estimated sources based on the sLORETA inverse solution were visualized
in the 3D brain region of the pre-clinical model, the coordinates of the identified target
irritative regions were scaled using Paxinos and Watson’s Atlas (G. Paxinos and C.
Waston, 2007) with respect to the rat brains to identify the tissue blocks to perform
immunohistochemistry. For scaling, known coordinates (0.0) of bregma (B1) and a
length of a point (L1) (-9.3 mm from B1) from the anterior end were used as reference
from Paxinos and Watson’s atlas. In the rat brains the length of the point (L2) from the
anterior end was measured (all length measurements were considered in the anterior to
the posterior direction). This information was used to determine coordinates of bregma
in rat brains (B2) and to calculate scaling factor (~0.74 for each rat). Product of scaling
factor and known distance of the target irritative regions from the bregma (B1) obtained
from source localization gave us real-time coordinates of target regions in the rat brains.
Tissue blocks of 3mm thickness around the target region were determined for
immunohistochemistry.
Immunohistochemistry of tissues is a powerful tool used to demonstrate the
presence or absence of an antigen. The immunocytochemical staining of brain tissue can
be compromised by factors such as time of tissue dissection, type of fixation and storage
time in fixative. Sometimes an animal has to go through different research studies
which make it difficult to obtain fresh brain tissue, or brain tissue that has been in
fixative for a short time for scientific research purposes and may not be available until
after several months of fixation. If fixed for longer times, the antigens are masked by
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crosslinking of proteins by aldehyde over fixation. Proteolytic enzyme predigestion is
often used to unmask the antigens (e.g., Battiflora and Kopinski, 1986) but the results
are not satisfactory with over fixed tissue. Shi et al. (1991) described a method of
antigen retrieval from formalin-fixed, paraffin-embedded human brain sections based on
microwave heating in metal solutions. However no single methodology is available to
immunostain all the antigens in rat brains that are fixed for long times. Here we
demonstrate a procedure to process and immunostain whole brains of focal epileptic rat
models that have been fixed for few months to a year and to identify three categories of
focal epilepsy specific biomarkers namely, anatomical, inflammatory and functional
with fluorescence immunohistochemistry.

2.5.1 FIXATION AND TISSUE PROCESSING
Whole animal perfusion was performed on an epileptic Wistar rat after EEG
recordings (Gage, G, et al, 2012). The brain was dissected and preserved in fixative (4%
paraformaldehyde) for few months till brain sources were identified by applying EEG
source analysis as mentioned before. Prior to immunohistochemical staining brain was
removed from fixative and washed with distilled water for 3-4 hrs. Following washing,
rat brain was incubated in a 4% aluminum chloride solution at room temperature for
about 12 hours before heating in microwave for 10 minutes with 1 minute interval after
5 minutes. Dimensions of brain were measured before and after heating to calculate
scaling factor to compensate for shrinking of brain upon heating. Accurate position of
Bregma was calculated from the scaling factor. Brain tissue was kept in 30% sucrose
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solution at 40C for cryoprotection prior to the sectioning. After about 3 days when tissue
sinks in sucrose solution, it was taken out and placed on the solid mold with the coronal
matrix with slots positioned 1 milimeter (mm) apart. With this mold a 3 mm coronal
segment of interest of rat brain was cut and positioned at the centre of a cubical plastic
mold filled with tissue freezing medium which supports the tissue during cryostat
sectioning because of its highly viscous and water soluble properties. Tissue was then
snap frozen in liquid nitrogen, plastic mold peeled off and tissue block was loaded on
cryostat head with the help of specimen disc. Tissue block was allowed to equilibrate at
-220C for 1 hr.

2.5.2 SECTIONING WITH CRYOSTAT
The frozen tissue block was mounted on the cryostat head and its orientation was
kept in the proper x-y plane with reference to the blade. A well oriented tissue block
will first meet the blade at the centre of the block. After mounting the chuck with frozen
tissue embedded in tissue freezing medium, first step was the trimming. The face of
tissue block needs to be trimmed till a desired depth in the tissue is reached. Each
clockwise rotation of the hand wheel advanced the mounted tissue block in the coronal
direction as per the set thickness (30μm). In case of focal epileptic rats, sectioning
should be precise to the target area as determined from the BOLD signal evoked by
IEDs. The target area was scaled to real-time coronal coordinates using Paxinos and
Watson’s Atlas (G. Paxinos and C. Waston, 2007). While sectioning, the coronal
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coordinates at which serial sections were taken were tracked by thickness and the
number of section from anterior-to-posterior direction.

2.5.3 IMMUNOHISTOCHEMICAL STAINING
Sections on glass slides were rehydrated with 0.01M phosphate buffered saline
(PBS). The endogenous peroxidase activity was suppressed by incubating the sections
in 3% hydrogen peroxide and 0.2% Triton X-100 in PBS for 30 minutes. Sections were
washed and incubated in 3% bovine serum albumin (BSA) in PBS for 1 hour to block
non specific antibody binding to the tissue before incubation in primary antibodies
followed by secondary antibodies for 1 hr each. Both the primary and secondary
antibodies were diluted in PBS.
Serial tissue sections of 30μm thickness were double immunostained using a
principle of sequential immunostaining method as described below.
1. Permeabilization and endogenous peroxidase blocking step: Apply 0.2% Triton X100 with 3% hydrogen peroxide in 0.01M PBS for 30 minutes.
2. Wash the sections with PBS for 10 mins minutes. Remove the excess PBS with a
dropper or pipette. Repeat three times.
3. Blocking step: Incubate the sections in 3% Bovine Serum Albumin (BSA) in 0.01M
PBS for 60 minutes to block unspecific binding of the antibodies.
4. Incubate sections with the first primary antibody in 2% BSA in 0.01M PBS in for 1
hour at room temperature.
20

5. Decant the first primary antibody solution and wash the cells three times in PBS, 10
minutes each wash.
6. Incubate cells with first secondary antibody (labelled with Fluorochrome-1) in 2%
BSA in 0.01M PBS for 1 hour at room temperature in dark.
7. Decant the first secondary antibody solution and wash three times with PBS for 10
minutes each in dark.
8. Incubate cells with the second primary antibody in 2% BSA in 0.01M PBS in the
dark for 1 hour at room temperature or overnight.
9. Decant the second primary antibody solution and wash sections three times with PBS
for 10 minutes each in dark.
10. Incubate cells with second secondary antibody (labelled with Fluorochrome-2) in
2% BSA for 1 hr at room temperature in dark.
11. Decant the second secondary antibody solution and wash three times with PBS for
10 minutes each in dark.
12. Remove excess of the PBS from the sides of the slide and cover slip sections with
mounting medium (ProLong® Diamond Antifade Mountant).
For biomarker staining experiments following biomarker staining protocols were
applied on serial tissue sections (30μm).
1. Neurofilament (SMI311) staining.
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2. TNF-α and GFAP sequential double immunostaining.
3. HMGB1 and GFAP sequential double immunostaining.
4. IL-1β and GFAP sequential double immunostaining.
5. GABAARα6 and Neurofilament (SMI311) sequential double immunostaining.
6. mGluR5 and GFAP sequential double immunostaining.
7. NMDAR2B and Neurofilament (SMI311) sequential double immunostaining.
8. Nissl immunostaining.
For data analysis biomarkers were grouped in three categories as anatomical,
inflammatory and functional biomarkers and details about reagents used are given
following sections.
2.5.3.1 ANATOMICAL BIOMARKER STAINING
The sections were incubated for 1 hour at room temperature with one of the
following primary antibody mouse anti-neurofilament (SMI 311, 1:2000). Sections were
washed and incubated with respective secondary antibody: Bovine anti-mouse IgG (sc362246, 1:400). For Nissl staining sections were incubated for an hour with Neurotrace
stain (N-21480, 1:300) after permeabilization (0.2% Triton X-100) step.

2.5.3.2 INFLAMMATORY BIOMARKER STAINING
The sections were incubated for 1 hour at room temperature with one of the
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following primary antibodies: rabbit anti-IL-1β (sc-7884, 1:300), goat anti-TNF-α (sc1350, 1:300), rabbit anti-HMGB1 (ab79823, 1:500). Sections were washed and
incubated with respective secondary antibodies: donkey anti - rabbit IgG (Alexa Fluor
680, 1:1000), donkey anti-goat IgG (sc-362255, 1:300), donkey anti - rabbit IgG (Alexa
Fluor 680, 1:1000). For GFAP staining sections were incubated for an hour with
primary monoclonal mouse Anti-Glial Fibrillary Acidic Protein-Cya3 (Sigma C9205,
1:500).

2.5.3.3 FUNCTIONAL BIOMARKER STAINING
The sections were incubated for 1 hour at room temperature with one of the
following primary antibodies: rabbit anti-NMDAR2B (AB1557P, 1:500), goat antimGluR-5 (sc-47147, 1:300), rabbit anti-GABAA Receptor alpha6 (AB 5610, 1:300).
Sections were washed and incubated with respective secondary antibodies: donkey anti
- rabbit IgG (Alexa Fluor 680, 1:1000), donkey anti-goat IgG (sc-362255, 1:300),
donkey anti - rabbit IgG (Alexa Fluor 680, 1:1000).

2.5.3.4 DATA COLLECTION AND ANALYSIS
To evaluate the IED-generating irritative regions, localized by using sLORETA
inverse solution, coronal sections from corresponding cortical region in seven FCD rat
brains were photographed with a Delta Vision Elite System. Raw images were
processed using background subtraction feature in Image-J open source software.
Number of Nissl bodies, perivascular cuffing and number of neuronal processes were
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counted using cell counter plug-in for Image-J software. Perivascular cuffing structure
was counted as continuous vasculature visible in photographs. Expression of all other
epilepsy specific biomarkers were computed as stained area as number of pixels in an
image after applying frequency threshold to avoid detecting background signal using
ImageJ software. For Each rat, average of six 20X images spanning cortical thickness
for each biomarker from target region were considered for analysis. Similarly control
data were collected and analysed from contra-lateral cortex. In this way target and
control data was collected from seven chronic epileptic rat brains. To determine the
distribution of the data, Q-Q plot (probability plot) a graphical method was employed
where linearity of data suggests normal distribution. Based on the distribution of the
data, statistical analyses were performed using Paired t-test where data were normally
distributed and Wilcoxson’s Signed Rank test where data were not normally distributed.
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3. RESULTS
3.1 SOURCE LOCALIZATION
Once all procedures are properly applied, estimated sources can be visualized in
3D brain region of the pre-clinical model. Figure 1 (A) show step wise methodology
applied on preclinical rat models of FCD to determine the estimated source from
localization of spikes and sharp-waves from IEDs. In addition, Figure-2 and 3 display
classification of subtype spikes and sharp-waves from IEDs. This methodology was
successfully applied to seven preclinical rat models and a target irritative region was
decided for each rat based on the criteria as given in Table-1. For each rat, number of
clearly classified averaged spikes and sharp-waves were localized separately (IEDs in
Table-1). Each spike and sharp-wave gave certain localized regions represented by
assigned numbers (localized structures in Table-1, where structures listed as most
frequent to least frequent) according to the Paxinos–Watson atlas and the averaged
MRI. From this data, for each rat most frequently localized region (most frequent
structure in Table-1) was considered as target irritative region for further histological
analysis. These results support the capability of the applied methodologies to record
high-resolution EEG on rats with focal epilepsy and to conduct source analysis using
the recorded EEG.
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Table-1: Criteria for source determination

Rat

1882

1884

2225

2223

1888

1894

1900

Localized
Structures

IEDs
Spikes

Sharp
waves

3

3

4

3

4

5

2

2

3

3

4

2

3

3

67,6,56,50,52,59,
80,84,63,5,60,34,
12,82,72

20,68,82,50,52,19,
60,6,67,84

79,82,52,87,67,80,
88,19,20,68,6,34,
43,12,15,53,54

43,75,95,76,67,12,
27,14,31,2,32,69,
94,92

47,80,82,34,79,12,
14,36,84,32,33

46,39,19,7,12,96,5,
45,6,40,35,20,69,3
1,14,55,89,43,44

32,52,34,12,68,54,
69,19,79,53,96,15,
6,14,5
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46
RIGHT
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32
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3.2 ANATOMICAL BIOMARKERS
We used Nissl staining with 0.2% triton X-100 and NeuroTrace stain (N21478,
Invitrogen) method to detect the Nissl bodies which are large granular endoplasmic
reticulum with rosettes of free ribosomes in the neurons. Nissl bodies show changes
under various pathological conditions.

Figure-(4): Anatomical Biomarkers. Nissl & Neurofilament (SMI-311) staining.
Scale bars: 50μm.
We observed that cortical neurons in the control group showed organized
orientation compared to Nissl staining observed in target cortex as shown in figure-4.
We also reported neuronal loss as indicated by number of Nissl bodies (figure-5)
compared in control and target area (p-value< 0.01).
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Figure-(5): Statistical representation of Anatomical biomarkers. Bars represent standard
error of mean (SEM). *P < 0.05; **P<0.01.

Overexpression of SMI311 positive neurofilaments is another important feature
in FCD. These neurofilaments targeted with monoclonal anti-SM311 antibody enable to
identify the presence of abnormally large pyramidal neurons often known as
cytomegalic neurons, frequently grouped in cell clusters, with increased expression of
SMI311 positive neurofilaments (figure-4), particularly in the apical dendrites. We
analysed over expression of SMI311 positive neurofilaments in target area by counting
the neuronal processes (p-value< 0.01) and by measuring the total area of neuronal
processes (p-value< 0.01) in comparison with control cortex as presented in figure-5.
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3.3.1 INFLAMMATORY BIOMARKERS
Expression of Glial Fibrillary Acidic Protein (GFAP) is associated with FCD.
GFAP is a useful marker which was a target for monoclonal anti-GFAP antibody
(Sigma C9205) to demonstrate the increased glial activity and presence of astrocytes
which are abnormal in their size and orientation (figure-8) in the pathology of FCD. The
GFAP expression was quantified by computing total stained area of glial processes (pvalue< 0.01) as shown in figure-10. Neuroinflammation in FCD can be identified by
release and presence of specific inflammatory agents such as Interleukin 1 beta (IL-1β),
tumor necrosis factor alpha (TNF-α) in inflamed cortical tissue which activates and
triggers further immune response.

Fig-(6): Inflammatory Biomarkers. IL-1β, HMGB1 & TNF-α staining.
Scale bars: 50μm.
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Figure-(7): Statistical representation of Inflammatory biomarkers. Bars represent
standard error of mean (SEM). *P < 0.05; **P<0.01.
Significantly increased expression of IL1β and TNFα in target area was
demonstrated by comparing stained area with control cortex (p-value< 0.05, p- value<
0.01 respectively) (figures-6 and 7). Also, IL-1β was found to be colocallized with
GFAP at perivascular cuffing (figure-8). High mobility group protein 1 (HMGB1)
secreted by immune cells and inflamed cells as an indicator of cell death during
neuroinflammatory process. Presence of HMGB1 was confirmed by HMGB1: rabbit
polyclonal antibody (Pharmigen, 1:100, Maroso et al., 2010). HMGB1 expression was
found to be significantly increased in target area (p-value< 0.01) (figures-6 and 7).
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Figure-(8): IL-1β and GFAP Co-registration. Scale bars: 50μm.

3.3.2 PERIVASCULAR CUFFING
We report numerous diffuse and patchy areas of infiltration of the cortex and white
matter by inflammatory cells, predominantly glia defined as perivascular cuffing
(figures-9). Sections from target area showed intensive perivascular cuffing (p-value<
0.05) (figure-10) underlined by presence of glial cells around inflamed vasculature. The
astrocytes were hypertrophied and increased in number.
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Figure-(9): Perivascular Cuffing. GFAP staining. Scale bars: 50μm.

Figure-(10): Statistical representation of Perivascular Cuffing. Bars represent standard
error of mean (SEM). **P<0.01.
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3.4 FUNCTIONAL BIOMARKERS
Functional markers are associated with specific post-translational changes in the
pathology of FCD. Increased glutamate function which is associated with
hyperexcitability in epileptogenic cortex was analysed with amplified expression of the
NR2B subunit of the N-methyl-D-aspartate glutamate receptor (NMDR) (p-value<
0.05) (figures-11 and 12) and expression of group I metabotropic glutamate receptor 5
(mGluR5) in target area was identified (p-value< 0.001) (figures-11 and 12). NR2B was
found to be intensively co-localized with neurofilaments in target area (figures-13)
where as mGluR5 was poorly co-registered with GFAP (figures-14). The inhibitory
function of gamma-aminobutyric acid (GABA)ergic system was observed by analysing
the expression of the GABAA-receptor α-6 subunit by directing anti-GABAAr α-6
rabbit polyclonal antibody against it. We found no significant difference between
localized and control cortex (figures-11 and 12).
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Figure-(11): Functional Biomarkers. NR2B, GABAA-r-α-6 & mGluR5 staining.
Scale bars: 50μm.

Figure-(12): Statistical representation of Functional biomarkers. Bars represent standard
error of mean (SEM). *P<0.05; ***P<0.001.
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Figure-(13): Co-registration of NR2B and SMI-311. Scale bars: 50μm.

Figure-(14): Co-registration of mGluR5 and GFAP. Scale bars: 50μm.
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4. DISCUSSION
The PI has developed several experimental and analytical tools in the past to
study the Wistar rats. This constitutes the main reason for modifying the (Colciaghi et
al., 2011) model, which was originally developed using Sprague–Dawley, for Wistar
rats. Rat model for FCD created by prenatal treatment of methylazoxymethanol acetate
(MAM) has a potential to mimic the pathologic and clinical features of FCD. We have
provided extensive evidence for the validity of this chronic epileptic model using EEG
data (Bae et al., 2015), IED-evoked fMRI response (Song et al., 2015), and intracranial
recordings (Song et al. 2016). This model gave us insights about the cellular and
molecular mechanisms of epileptogenesis which are evident with similar markers
observed human FCD subjects. Unfortunately, this model does not show presence of
balloon cells (abnormally large neurons with abundant cytoplasm) which are observed
in human FCD subjects.
4.1 SOURCE LOCALIZATION
A methodology to non-invasively record multichannel EEG in a preclinical animal
model of chronic focal epilepsy is described. The details for the recording and analysis
procedures are provided. There were key factors to consider achieving successful
results. First, obtaining high quality signals is essential during EEG recordings. There is
a lot of evidence about the negative effect of different type of anesthesia on the genesis
of IEDs which was confirmed by our preliminary experiments where EEG recording
was performed under isoflurane (2%). These negative effects were significantly absent
in EEG recordings performed under sedative (0.25mg dexdomitor). For this reason we
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employed a protocol where anesthesia induction was done with 5% isoflurane during
animal manipulation phase (i.e. fixing an animal to stereotaxic frame, scalp shaving) the
reducing isoflurane slowly to 0.5% and obtaining EEG recording under sedative.
Second, for brain source imaging, generating proper volume conductor model is crucial.
Each surface of the model should be co-registered. Even though we have applied source
analysis procedures using Brainstorm (Tadel F, et al, 2011), other open softwares
(Delorme, A, et al, 2004; Oostenveld R, et al, 2011) and commercial products (Koessler
L, et al, 2010; Manganotti P, et al, 1998) can be used. Also, besides sLORETA, other
inverse solutions such as multiple dipole models and Beamformer can be applied
(Baillet S, et al, 2001). Our results support the importance for a precise classification of
IED markers from EEG recordings to determine the IED-generating irritative regions in
a rat with focal epilepsy and further to evaluate their relationship with the underlying
mechanisms for seizure initiation (Song Y, et al, 2014). In addition, it has been shown
that EEG source localization for such specific IEDs showed a good correspondence with
the respective BOLD activation and deactivation regions (Bae J, et al, 2015).
We believe that the use of this methodology will produce similar results when
applied to patients with FCD, in this regard preparing IRB protocols for the evaluation
of this and other aspects of the methodology in human dataset will be a near future
prospect. Moreover, the use of preclinical models will help us understand the
capabilities and limitations of EEG source localization in epilepsy (Birot G, et al, 2014).
Accurate estimation of brain sources underling epileptogenesis is crucial for therapeutic
strategies and resective surgical planning. Also, having a standard platform for EEG
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recording in rats will be useful for the evaluation of the effectiveness of several antiepileptic drugs in preclinical trials. The entire methodology presented in this study is
extendable to other experimental conditions and brain disorders. This methodology has
been developed for Wistar rats because of the existence of an MRI atlas for this
particular rat strain. However, it can be applied to other rodent types with respective
standard format of atlas including mouse (Hawrylycz M, et al, 2014), Sprague-Dawley
rats (Schweinhardt P, et al, 2003), and Paxinos and Watson rats (Schwarz A, et al,
2006). We have provided extensive evidence for the validity of the used MAM-PILO
chronic epileptic model using EEG data (Bae et al., 2015), IED-evoked fMRI response
(Song et al., 2015), and intracranial recordings (Song et al. 2016).
4.2 ANATOMICAL BIOMARKERS
Hyperexcitability in a neuronal tissue is a pathological condition leading to
epileptic seizures underlines the focally injured tissue in FCD (Badawy RA, et al, 2012)
characterized by an abnormal neuronal activity in surrounding cortical tissue
contributing to epileptogenic region (Schiene K, et al, 1996; Eysel ET, et al, 1991). We
analyzed morphology and protein expressions of key biomarkers in IED-generating
irritative areas in FCD with seizures, to investigate the hypothesis that chronic epilepsy
induces pathological changes in the irritative areas. We found that the irritative area of
focal epileptic rats was characterized by the abnormal neurons over expressing
neurofilaments, as well as reduced neuronal mass demonstrated by Nissl staining.
Consistent results were reported previously in dysplastic compared to non-dysplastic
areas in type IIA and IIB FCD, (Thom M, et. al, 2005).
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4.3 INFLAMMATORY BIOMARKERS
Recent evidence strongly suggests that glia mediated inflammation plays a role
in the pathogenesis of seizures and epilepsy (Orrin D, et al, 2013). We found extensive
reactive gliosis (with altered astrocyte morphology) in localized irritative region which
corroborates finding that longer chronic epilepsy is associated with more intensive
reactive gliosis and astrocyte alterations in epileptogenic region, further evidence that
epilepsy is a progressive pathology (Finardi A, et al, 2013). Astrocytes undergo changes
in morphology, molecular composition, and proliferation in epileptogenic region. The
activation of astrocytes includes changes that vary with the severity and chronicity of
seizure pathology (Sofroniew, M.V, 2009). Reactive astrocytes has been reported in
animal models of epilepsy and in neural tissue from human patients with mesial
temporal sclerosis (MTS), focal cortical dysplasia (FCD), tuberous sclerosis complex
(TSC), Rasmussen’s encephalitis (RE), and glioneuronal tumors (Jabs R, et al. 2008;
Bauer J, et al, 2007; Binder D, et al, 2006). In case of Rasmussen’s encephalitis,
epilepsy with chronic brain inflammation, astrocytes are a specific target of immune
system, particularly cytotoxic T cells (Bauer J, et al, 2007). MTS, the most common
pathology associated with temporal lobe epilepsy (TLE), is characterized by astroglial
and microglial activation and proliferation (Wetherington J, et al, 2008), with increased
complexity of astroglial processes, often approaching glial scar-like formations in late
stage MTS (Martinian L, et al, 2009).
Astrocytes are closely related to the microvasculature and with their endfeet
ensheathing blood vessels (figure-8 and 9) known as perivascular cuffing contribute to
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blood-brain-barrier (BBB) function by releasing chemical signals that help to form and
maintain tight junctions between endothelial cells, thus regulating the exchange of water
and molecules between the blood and brain tissue (Orrin D, et al, 2013). We observed
perivascular cuffings and inflammatory glial nodules in epilepetic rats which were more
intense in target irritative areas. These structures have been attributed in the past to
tissue breakdown associated with frequent seizures (Theodore Rasmussen, et al, 1958).
The brain microvasculature undergoes several structural, molecular, and
functional changes in epilepsy. Vessel proliferation in TLE positively correlates with
seizure frequency (Rigau V, et al, 2007) and is associated with compromised BBB
permeability (Rigau V, et al, 2007; Marcon J, et al, 2009). Proinflammatory chemokines
and cytokines released by inflamed epileptogenic tissue can interact with their
respective receptors over expressed by brain microvasculature

in epilepsy, thus

compromising BBB permeability at multiple levels [e.g., by disrupting tight junction
proteins (Morin-Brureau M, et al. 2011), increased infiltration of leukocytes and viral
particles through the BBB into the brain parenchyma]. In response to inflammatory
cytokines, excessive leukocyte trafficking by interacting with adhesion molecules on
endothelial cells may alter BBB permeability to serum proteins and circulating
molecules (Fabene P, et al, 2008; Kim J, et al, 2009).
Glial cells play a critical role by maintaining balance between proinflammatory
and

anti-inflammatory

pathways.

Activated

glia

release

cytokines

inducing

transcriptional as well as, post-transcriptional signalling in the astrocytes and other
immune cells. Immune system and glia including astrocytes release IL-1β and high40

mobility group box 1 protein which activate nuclear factor kappa B (NF-kB), an
important regulator of proinflammatory gene expression which has been reported to be
upregulated in MTS and TSC tissue (Crespel A, et al, 2002; Maldonado M, et al, 2003).
In case of IL-1β and HMGB1 release, signaling occurs through activation of the proinflammatory IL-1 receptor/Toll-like receptor (IL1R/TLR) system. This system is
activated in epilepsy models and in human MTS, TSC, and FCD tissue (Vezzani, A. et
al. 2013; Maroso, M. et al. 2010; Zurolo, E. et al. 2011). Astrocytes help to limit the
immune response by controlling microglial activation. It has been demonstrated in invitro experimental settings that astrocytes can reduce the production of proinflammatory
and neurotoxic TNF-α, nitric oxide and reactive oxygen species from microglia to
inhibit microglial phagocytosis (Tichauer, J. et al. 2007). However, our results showed
increased TNF-α staining in target area with lack of colocalization with GFAP
indicating presence of proinflammatory immune response with neuronal source of
TNFα.
In in-vivo seizure models, astroglial cells are also key sources of antiinflammatory molecules such as the IL-1 receptor antagonist (IL-1ra), an endogenous
competitive IL-1 receptor blocker that controls IL-1β-mediated inflammation. IL-1ra
has powerful anticonvulsant effects in experimental seizure models (Vezzani, A. et al.
2000; Auvin, S. et al. 2010; Marchi, N. et al. 2009) and mice over expressing IL-1ra in
astrocytes were reported to be intrinsically resistant to seizures (Vezzani, A. et al.
2000). However, in MTS and experimental epilepsies, astrocyte expression of IL-1ra is
significantly lower than that of IL-1β (De Simoni, M.G. et al. 2000; Ravizza, T. et al.
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2006), which may explain poor anti-inflammatory response due to the dominance of
proinflammatory pathways over anti-inflammatory pathways which we demonstrate to
be consistent with our finding of IL-1β over expression in epileptogenic region. Also,
proinflammatory IL-1β was found to be colocallized with GFAP at perivascular cuffing
(figure-8) indicating active inflammation thus supporting previous study that report
astrocyte derived interleukin-1 beta (IL-1β) can compromise BBB integrity during
seizures (Librizzi, L. et al. 2012).
4.4 FUNCTIONAL BIOMARKERS
NMDA receptors (NMDAR) are likely to play an important role in
epileptogenesis because the NMDAR channels are permeable to Ca2+ which acts as a
secondary messenger in signalling attributed to synaptic plasticity (Kirkwood A, et al,
1993; Macdermott A.B., et al, 1986). Several reports are available about increased
expression of NR2B subunit of NMDA receptor in tissue resected from clinical patients
with drug-resistant epilepsy (Crino P, et al, 2001; Mathern G, et al, 1998; Najim I, et al,
2000; Ying Z, et al, 1998; Ying Z, et al, 1999). Mathern et al. (Mathern G, et al, 1998)
found increased NR2B expression in the hippocampi of epileptic patients. Crino P et al.
(2001) reported increased NR2B mRNA in dysplastic neocortical neurons in human
cortical dysplasia. In relevance to these findings, we demonstrate elevated NR2B
expression in localized irritative zone (figure-11 and 12) with more intense colocalization of NR2B subunits with neurofilaments (figure-13) in neuronal soma and
neuronal dendritic processes.
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So far, it is clear that cortical injuries are associated with abnormal excitability
of the adjacent neuronal networks focal epilepsy. It has been assumed that the
development of this abnormal neuronal activity is the result of an imbalance between
excitation and inhibition, where changes in inhibition are believed to play the most
important role (Imbrosci B, et al, 2011). An impaired inhibitory transmission has been
reported in several animal models of both traumatic and ischemic brain injury
(Buchkremer-Ratzmann I, et al, 1996; Mittmann T, et al, 1994). Functionally, the
impaired GABAergic transmission has been attributed to reduction in release of GABA
from presynaptic terminals (Li H, et al, 2002) and changes in the expression of GABA
receptors (Schiene K, et al, 1996). In an attempt to assess the inhibitory function at
localized epileptogenic tissue, we found no significant reduction (figure-12) in
GABAA-receptor-α6 subunit of GABA receptor family. To reach a proper conclusion
in this regard we need to analyse the expression profiles of entire GABA receptor
family and also need to take into account the previous studies (Schiene K, et al, 1996)
reporting differential GABAergic transmission in and around epileptic foci in
epileptogenic cortex.
Activation and high expression of group I metabotropic glutamate receptors
(mGluRs) may contribute to neuronal hyperexcitation, as suggested by the convulsant
action of group I agonists, which are responsible for seizure discharge and
epileptogenesis in different experimental models (Chapman AG, 1998; Wong R. et al,
1999). Neuronal mGluRs are known to have important roles in synaptogenesis and
synaptic plasticity and in pathophysiological processes (Chapman AG, 1998; Merlin L,
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et al, 1997). In our study we observed elevated expression of mGluR5 (p-value < 0.001)
in irritative region (figure-11 and 12) with the dominant source being neuronal mass as
evident from lack of co-localization of mGluR5 with GFAP (figure-14). Since
consistent findings were reported in similar study involving glioneuronal tumours (GG)
and dysembryoplastic neuroepithelial tumours from clinical patients associated with
chronic intractable epilepsy which are highly epileptogenic (Aronica E, et al, 2001), we
can speculate that chronic seizure activity could contribute to the strong expression of
mGluR5 in the neuronal component of the tumours although the role of group I
metabotropic glutamate receptors (mGluRs) is not completely understood (Bruno V, et
al, 1999; Herrero I, et al, 1998).
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5. CONCLUSION
In this study, we applied a standard non-invasive, multiple electrode scalp EEG
source imaging methodology in preclinical ‘double-hit’ rat models of focal epilepsy. We
were able to apply this methodology to evaluate preliminarily the underlying brain
sources of two types of IEDs. Proper classification of EIDs by using only information in
the IED waveform was performed and sLORETA inverse solution was obtained to
localize specifically classified IED subtypes.
In order to evaluate this methodology using histological biomarkers as gold
standards, we demonstrated a procedure to process and perform immunohistochemistry
on brains of chronic focal epileptic rats that have been long time under fixation (for a
few months to a year). We were successful in immunostaining three categories of focal
epilepsy specific biomarkers with fluorescence immunohistochemistry. The results
showed the existence of abnormal neuronal expression as well as glioreactivity, vascular
cuffing substantial inflammatory processes in irritative brain areas, independent whether
they were the seizure-onset zones or not. We conclude that chronic focal epilepsy
induces abnormal pathophysiological changes in the irritative areas; hence these
irritative zones are of clinical relevance for pre-surgical evaluation of patients with
refractory focal epilepsy and IED-based brain source imaging helps localize these
abnormal tissues (irritatives) highly prospective for epileptogenesis.
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